Medicon Hellas S.A. Share Price

Equities

MEDIC

GRS424003002

Advanced Medical Equipment & Technology

Market Closed - Athens S.E. 15:09:45 02/05/2024 BST 5-day change 1st Jan Change
2.96 EUR -1.33% Intraday chart for Medicon Hellas S.A. +1.37% -11.11%

Financials

Sales 2021 21.51M 23.08M 1.84B Sales 2022 20.77M 22.29M 1.78B Capitalization 16.35M 17.55M 1.4B
Net income 2021 3M 3.22M 257M Net income 2022 2M 2.15M 171M EV / Sales 2021 1.08 x
Net Debt 2021 1.75M 1.88M 150M Net Debt 2022 816K 875K 69.79M EV / Sales 2022 0.83 x
P/E ratio 2021
7.09 x
P/E ratio 2022
6.46 x
Employees 176
Yield 2021 *
-
Yield 2022
4.14%
Free-Float 55.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.33%
1 week+1.37%
Current month-3.58%
1 month-1.00%
3 months-6.03%
6 months-1.00%
Current year-11.11%
More quotes
1 week
2.85
Extreme 2.85
3.05
1 month
2.81
Extreme 2.81
3.06
Current year
2.81
Extreme 2.81
3.49
1 year
2.81
Extreme 2.81
4.40
3 years
2.01
Extreme 2.01
5.40
5 years
1.50
Extreme 1.5
5.40
10 years
0.23
Extreme 0.233
5.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 29/06/17
Director of Finance/CFO - -
Investor Relations Contact 70 -
Members of the board TitleAgeSince
Director/Board Member 41 29/06/17
Director/Board Member 74 29/06/17
Director/Board Member 45 29/06/17
More insiders
Date Price Change Volume
02/05/24 2.96 -1.33% 5,888
30/04/24 3 +0.33% 10,499
29/04/24 2.99 -0.33% 8,895
26/04/24 3 +4.53% 19,674
25/04/24 2.87 -2.71% 2,943

Delayed Quote Athens S.E., May 02, 2024 at 03:09 pm

More quotes
Medicon Hellas SA is a Greece-based company active in the health equipment sector. Its activities include research and development, production, and import and export of diagnostic products; the development of laboratory information systems; the import and distribution of in vitro diagnostics and automated analytical systems, such as Olympus for clinical chemistry, immunochemistry and lab automation, and Nihon Kohden for hematology, and the provision of cosmetic and body care products, such as make-up, anti-ageing and skin care products under the brand name Miss Beaute. Its laboratory information systems products include: Gi-Lab, which is a management system for medical laboratories; Gi-Maxima, a management program for medical centers, and Gi-Blood, which is an application that helps to connect various blood donation networks. On December 6, 2013, it merged by absorption of its subsidiary, Medicon Ltd.
More about the company